RO118794B1 - Metodă de tratament a unor stări dependente de steroizii gonadici - Google Patents

Metodă de tratament a unor stări dependente de steroizii gonadici

Info

Publication number
RO118794B1
RO118794B1 RO97-00117A RO9700117A RO118794B1 RO 118794 B1 RO118794 B1 RO 118794B1 RO 9700117 A RO9700117 A RO 9700117A RO 118794 B1 RO118794 B1 RO 118794B1
Authority
RO
Romania
Prior art keywords
gonadal
treatment
dependent conditions
steroid dependent
estrogen
Prior art date
Application number
RO97-00117A
Other languages
English (en)
Inventor
Gary D. Hogden
Audrey Philips
Original Assignee
Eastern Virginia Medical School
Ortho Pharmaceutical Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastern Virginia Medical School, Ortho Pharmaceutical Corporation filed Critical Eastern Virginia Medical School
Priority claimed from PCT/US1995/008996 external-priority patent/WO1996003138A1/en
Publication of RO118794B1 publication Critical patent/RO118794B1/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Invenţia se referă la o metodă de tratament a unor stări dependente de steroizii gonadici la un mamifer, prin reducerea furnizării de estrogen şi constă în aceea că se administrează un antagonist de GnRH într-o cantitate eficientă pentru a inhiba proliferarea ţesutului endometrial, fără stoparea substanţială a producţiei de estrogen endogen.
RO97-00117A 1994-07-22 1995-07-18 Metodă de tratament a unor stări dependente de steroizii gonadici RO118794B1 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27959394A 1994-07-22 1994-07-22
US08/467,860 US5658884A (en) 1994-07-22 1995-06-06 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
PCT/US1995/008996 WO1996003138A1 (en) 1994-07-22 1995-07-18 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens

Publications (1)

Publication Number Publication Date
RO118794B1 true RO118794B1 (ro) 2003-11-28

Family

ID=23069633

Family Applications (1)

Application Number Title Priority Date Filing Date
RO97-00117A RO118794B1 (ro) 1994-07-22 1995-07-18 Metodă de tratament a unor stări dependente de steroizii gonadici

Country Status (8)

Country Link
US (1) US5658884A (ro)
KR (1) KR970704460A (ro)
JO (1) JO1879B1 (ro)
LT (1) LT4341B (ro)
MY (1) MY121568A (ro)
RO (1) RO118794B1 (ro)
UA (1) UA51627C2 (ro)
ZA (1) ZA956099B (ro)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265393B1 (en) 1998-08-07 2001-07-24 Heinrichs William Leroy Prevention of endometriosis signs or symptons
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
WO2001021194A2 (en) * 1999-09-23 2001-03-29 Zentaris Ag Method for the therapeutic management of endometriosis and fallopian tube obstruction
US7005418B1 (en) 1999-09-23 2006-02-28 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
WO2012044830A1 (en) * 2010-10-01 2012-04-05 Indiana University Research And Technology Corporation Treatment of symptoms associated with menopause
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein

Also Published As

Publication number Publication date
UA51627C2 (uk) 2002-12-16
LT97021A (en) 1998-02-25
MY121568A (en) 2006-02-28
US5658884A (en) 1997-08-19
LT4341B (lt) 1998-05-25
JO1879B1 (en) 1996-07-25
KR970704460A (ko) 1997-09-06
ZA956099B (en) 1997-02-18

Similar Documents

Publication Publication Date Title
ZA957891B (en) Combination of an oploid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholosm and alcohol dependence
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
GR3033667T3 (en) Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
IL124459A0 (en) Antagonists of gonadotropin releasing hormone
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
GR3035774T3 (en) Substituted benzolactam compounds as substance p antagonists
IL126082A0 (en) Compositions for alleviating neuropathic pain comprising prosaposin-derived peptides
WO2002005791A3 (en) Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor
BG102668A (en) Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
BG105534A (en) 5ht1 means and method for the treatment of migraine
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
HK1070003A1 (en) Continuous sulfatase inhibiting progestogen hormone replacement therapy
UA70925C2 (uk) Спосіб лікування естрогенстимульованого раку
PL319784A1 (en) Keratinocytic growth factor analoques
ZA951974B (en) Bradykinin antagonist peptides incorporating N-subsituted glycines
RO118794B1 (ro) Metodă de tratament a unor stări dependente de steroizii gonadici
YU7901A (sh) Nova primena derivata taksoida
MY117009A (en) Estrogen agonist/antagonists treatment of atherosclerosis
AP9801261A0 (en) Farnesyl transferase inhibitors in combination with HMG COA reductase inhibitors for the treatment of cancer.
BG101158A (en) Establishment of tonic overial secretion of estrogen for continuous therapeutical regimen
EP0891186A4 (en) NASAL ADMINISTRATION OF SUBSTANCES FOR THE TREATMENT OF THE TARDIVES EMESIS
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
PL331321A1 (en) Treatment pf psychotic disorders
SI0758890T1 (ro)
IL139303A0 (en) Treatment of arthritis and other similar conditions